Ashwin K. Rajgopal
ASTER(CA)
Publications by Year
Research Areas
Intraperitoneal and Appendiceal Malignancies, Ovarian cancer diagnosis and treatment, Appendicitis Diagnosis and Management, Breast Cancer Treatment Studies, Reproductive Biology and Fertility
Most-Cited Works
- → Transmission of colistin‐resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center(2002)117 cited
- → Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis(2003)68 cited
- → Pressurized intraperitoneal aerosol chemotherapy (PIPAC) versus intravenous chemotherapy in unresectable peritoneal metastases secondary to platinum-resistant ovarian cancer: Interim analysis of Indian randomized control trial.(2022)6 cited
- → Development and internal validation of clinical prediction models for outcomes of complicated intra-abdominal infection(2021)6 cited
- → Cytoreductive surgery plus HIPEC for advanced epithelial ovarian cancer: Analysis from a multicentric national Indian HIPEC registry of 1,470 patients—An ISPSM Collaborative study.(2022)2 cited
- → Prevalence of Escherichia coli O157 on the hands of food‐workers(2003)2 cited
- → Bowel anastomosis before or after HIPEC: A prospective comparative study in patients undergoing CRS+HIPEC for peritoneal surface malignancy at a tertiary care cancer center in India.(2020)2 cited
- → Triple blinded prospective study assessing the impact of genomics: EndoPredict and artificial intelligence Watson for Oncology (WFO) on MDT’s decision of adjuvant systemic therapy for hormone receptor positive early breast carcinoma.(2019)2 cited
- → Abstract P3-03-40: A prospective two arm comparative study of indo-cyanine green (ICG) enhanced fluorescence imaging vs conventional methods (blue dye and radiocolloid/hand held gamma probe) for sentinel lymph node detection in breast cancer - Going beyond the horizon(2019)1 cited
- → CRS-HIPEC following neo-adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) with systemic chemotherapy in primarily advanced inoperable epithelial ovarian cancer: An ISPSM collaborative study.(2024)1 cited